While true that it is a downgrade on expectations from a few months prior it is still a considerable upgrade from FY19 performance. In FY19 PBT was -$2m. This year it will be +$4m. And yet the stock is exactly where it was after the FY19 results were reported. Either it was too expensive back then or it is too cheap right now. I'm hoping for the latter but acknowledge the company has some work to do to restore confidence.
Ann: Adacel Market Update, page-6
Add ADA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.06M | |||
| Open | High | Low | Value | Volume |
| 46.0¢ | 46.0¢ | 46.0¢ | $7.181K | 15.61K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10874 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 340 | 1 |
View Market Depth
| Last trade - 14.42pm 03/09/2024 (20 minute delay) ? |
| ADA (ASX) Chart |